These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20445955)

  • 1. Axo-glial antigens as targets in multiple sclerosis: implications for axonal and grey matter injury.
    Derfuss T; Linington C; Hohlfeld R; Meinl E
    J Mol Med (Berl); 2010 Aug; 88(8):753-61. PubMed ID: 20445955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurofascin as a novel target for autoantibody-mediated axonal injury.
    Mathey EK; Derfuss T; Storch MK; Williams KR; Hales K; Woolley DR; Al-Hayani A; Davies SN; Rasband MN; Olsson T; Moldenhauer A; Velhin S; Hohlfeld R; Meinl E; Linington C
    J Exp Med; 2007 Oct; 204(10):2363-72. PubMed ID: 17846150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collateral bystander damage by myelin-directed CD8+ T cells causes axonal loss.
    Sobottka B; Harrer MD; Ziegler U; Fischer K; Wiendl H; Hünig T; Becher B; Goebels N
    Am J Pathol; 2009 Sep; 175(3):1160-6. PubMed ID: 19700745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies.
    Koike H; Kadoya M; Kaida KI; Ikeda S; Kawagashira Y; Iijima M; Kato D; Ogata H; Yamasaki R; Matsukawa N; Kira JI; Katsuno M; Sobue G
    J Neurol Neurosurg Psychiatry; 2017 Jun; 88(6):465-473. PubMed ID: 28073817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral autoimmunity in multiple sclerosis.
    Meinl E; Derfuss T; Krumbholz M; Pröbstel AK; Hohlfeld R
    J Neurol Sci; 2011 Jul; 306(1-2):180-2. PubMed ID: 20817206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance is futile: antineuronal autoimmunity in multiple sclerosis.
    Huizinga R; Linington C; Amor S
    Trends Immunol; 2008 Feb; 29(2):54-60. PubMed ID: 18182323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical pathology in multiple sclerosis.
    Stadelmann C; Albert M; Wegner C; Brück W
    Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axonal degeneration as substrate of fractional anisotropy abnormalities in multiple sclerosis cortex.
    Preziosa P; Kiljan S; Steenwijk MD; Meani A; van de Berg WDJ; Schenk GJ; Rocca MA; Filippi M; Geurts JJG; Jonkman LE
    Brain; 2019 Jul; 142(7):1921-1937. PubMed ID: 31168614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untapped targets in multiple sclerosis.
    Meinl E
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S12-5. PubMed ID: 22206760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.
    Derfuss T; Parikh K; Velhin S; Braun M; Mathey E; Krumbholz M; Kümpfel T; Moldenhauer A; Rader C; Sonderegger P; Pöllmann W; Tiefenthaller C; Bauer J; Lassmann H; Wekerle H; Karagogeos D; Hohlfeld R; Linington C; Meinl E
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8302-7. PubMed ID: 19416878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
    Desmazières A; Sol-Foulon N; Lubetzki C
    Mult Scler; 2012 Feb; 18(2):133-7. PubMed ID: 22217583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
    Leitner H
    Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the origins of grey matter damage in multiple sclerosis.
    Calabrese M; Magliozzi R; Ciccarelli O; Geurts JJ; Reynolds R; Martin R
    Nat Rev Neurosci; 2015 Mar; 16(3):147-58. PubMed ID: 25697158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation.
    Bitsch A; Schuchardt J; Bunkowski S; Kuhlmann T; Brück W
    Brain; 2000 Jun; 123 ( Pt 6)():1174-83. PubMed ID: 10825356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic analysis of axo-glial membrane specializations in the demyelinated central nervous system.
    Soffer D; Raine CS
    Brain Res; 1980 Mar; 186(2):301-13. PubMed ID: 7357456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
    Brück W
    J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes.
    Zeis T; Kinter J; Herrero-Herranz E; Weissert R; Schaeren-Wiemers N
    J Neuroimmunol; 2008 Dec; 205(1-2):10-9. PubMed ID: 18950873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Sclerosis: Mechanisms of Disease and Strategies for Myelin and Axonal Repair.
    Lemus HN; Warrington AE; Rodriguez M
    Neurol Clin; 2018 Feb; 36(1):1-11. PubMed ID: 29157392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.